These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9548204)

  • 1. In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
    Tanaka E; Breimer DD
    J Clin Pharm Ther; 1997 Aug; 22(4):237-49. PubMed ID: 9548204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease.
    Tanaka E
    J Clin Pharm Ther; 1998 Jun; 23(3):161-70. PubMed ID: 9831966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical appraisal of 13C breath tests for microsomal liver function: aminopyrine revisited.
    Pijls KE; de Vries H; Nikkessen S; Bast A; Wodzig WK; Koek GH
    Liver Int; 2014 Apr; 34(4):487-94. PubMed ID: 24428683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1.
    Kurata N; Nishimura Y; Iwase M; Fischer NE; Tang BK; Inaba T; Yasuhara H
    Xenobiotica; 1998 Nov; 28(11):1041-7. PubMed ID: 9879636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
    Frye RF; Branch RA
    Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aminopyrine breath test.
    Perri F; Pastore M; Annese V; Andriulli A
    Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?
    Tanaka E; Kurata N; Yasuhara H
    J Clin Pharm Ther; 2003 Jun; 28(3):157-65. PubMed ID: 12795773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cytochrome P450 activity by a five-drug cocktail approach.
    Zhu B; Ou-Yang DS; Chen XP; Huang SL; Tan ZR; He N; Zhou HH
    Clin Pharmacol Ther; 2001 Nov; 70(5):455-61. PubMed ID: 11719732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis.
    Bastien MC; Leblond F; Pichette V; Villeneuve JP
    Can J Physiol Pharmacol; 2000 Nov; 78(11):912-9. PubMed ID: 11100940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
    Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
    Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity.
    Leclercq I; Horsmans Y; Desager JP; Pauwels S; Geubel AP
    Br J Nutr; 1999 Oct; 82(4):257-62. PubMed ID: 10655974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of liver function in liver diseases using drugs as indicators].
    Tanaka E; Yasuhara H
    J Toxicol Sci; 1997 Aug; 22(3):APP 79-87. PubMed ID: 9379499
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans.
    Berthou F; Goasduff T; Lucas D; Dréano Y; Le Bot MH; Ménez JF
    Pharmacogenetics; 1995 Apr; 5(2):72-9. PubMed ID: 7663531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of liver metabolic function. Clinical implications.
    Brockmöller J; Roots I
    Clin Pharmacokinet; 1994 Sep; 27(3):216-48. PubMed ID: 7988103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cytochrome P450 2E1 activity by the [14C]nitrosodimethylamine breath test.
    Bastien MC; Villeneuve JP
    Can J Physiol Pharmacol; 1998; 76(7-8):756-63. PubMed ID: 10030456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs.
    Zheng L; Lu Y; Cao X; Huang Y; Liu Y; Tang L; Liao SG; Wang AM; Li YJ; Lan YY; Wang YL
    J Ethnopharmacol; 2014 Dec; 158 Pt A():276-82. PubMed ID: 25446640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13C-breath tests in the study of microsomal liver function.
    Nista EC; Fini L; Armuzzi A; Candelli M; Zocco MA; Cazzato IA; Merra G; Finizio R; Miele L; Grieco A; Gasbarrini G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):33-46. PubMed ID: 15209153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsomal function in hepatitis B surface antigen healthy carriers: assessment of cytochrome P450 1A2 activity by the 14C-caffeine breath test.
    Horsmans Y; De Koninck X; Geubel AP; Pauwels S
    Pharmacol Toxicol; 1995 Oct; 77(4):247-9. PubMed ID: 8577634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.